0001209191-19-005512.txt : 20190128 0001209191-19-005512.hdr.sgml : 20190128 20190128161358 ACCESSION NUMBER: 0001209191-19-005512 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190125 FILED AS OF DATE: 20190128 DATE AS OF CHANGE: 20190128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEUNG GABRIEL CENTRAL INDEX KEY: 0001236183 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37565 FILM NUMBER: 19545598 MAIL ADDRESS: STREET 1: C/O PERNIX THERAPEUTICS HOLDINGS, INC. STREET 2: 10 NORTH PARK PLACE, SUITE 201 CITY: MORRISTOWN STATE: NJ ZIP: 07960 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NovoCure Ltd CENTRAL INDEX KEY: 0001645113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF BUSINESS PHONE: 44 (0)15 3475 6700 MAIL ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF FORMER COMPANY: FORMER CONFORMED NAME: Novocure Ltd DATE OF NAME CHANGE: 20150615 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-01-25 0 0001645113 NovoCure Ltd NVCR 0001236183 LEUNG GABRIEL C/O NOVOCURE INC. 20 VALLEY STREAM PARKWAY, SUITE 300 MALVERN PA 19355 1 0 0 0 Ordinary Shares 2019-01-25 4 M 0 20000 3.44 A 80000 D Ordinary Shares 2019-01-25 4 S 0 20000 50.00 D 60000 D Options to Buy Ordinary Shares 3.44 2019-01-25 4 M 0 20000 0.00 D 2021-09-14 Ordinary Shares 20000 104743 D These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leung. These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leung. Fully vested as of the date hereof. /s/ Kimberly Burke, Attorney in fact for Kinyip Gabriel Leung 2019-01-28